COVID-19 Dysautonomia

Brent P Goodman, Julie A Khoury, Janis E Blair, Marie F Grill, Brent P Goodman, Julie A Khoury, Janis E Blair, Marie F Grill

Abstract

Objective: To report a case series of dysautonomia associated with COVID-19 infection. Methods: This is a retrospective review of patients evaluated in the autonomic clinic at our institution with suspected signs and symptoms of dysautonomia who underwent formal evaluation, including autonomic testing. Results: Six patients were identified with signs and symptoms suggestive of dysautonomia who underwent autonomic testing. All patients had symptoms typical of COVID-19 infection, though none were hospitalized for these or other symptoms. All patients reported symptoms of postural lightheadedness and near-syncope, fatigue, and activity intolerance. Five patients reported the onset of autonomic symptoms concomitant with other COVID-19 symptoms, with the other patient reporting symptom onset 6 weeks following initial COVID-19 symptoms. Autonomic testing demonstrated an excessive postural tachycardia in 4 patients, a hypertensive response with head-up tilt in 3 patients, orthostatic hypotension in 1 patient, and sudomotor impairment in 1 of the patients with excessive postural tachycardia. Conclusions: We present clinical features and results of autonomic testing in 6 patients with a history COVID-19 infection. While all patients reported typical features of orthostatic intolerance, fatigue, and activity intolerance, the results of autonomic testing were heterogenous, with orthostatic hypotension in 1 patient, excessive postural tachycardia typical of postural tachycardia syndrome in 4 patients, and postural hypertension in 3 patients.

Keywords: COVID-19; POTS; autonomic neuropathy; dysautonomia; orthostatic hypotension; postural tachycardia syndrome.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Goodman, Khoury, Blair and Grill.

Figures

Figure 1
Figure 1
Autonomic Findings in COVID-19 Dysautonomia patient. (A) Reduced sweating on quantitative sudomotor axon reflex testing in the foot (arrow); normal elsewhere. (B) Abnormal, excessive increase in heart rate (61 beats per minute) with head-up tilt. Heart rate is depicted in green. Blood pressure in red.

References

    1. Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, Sánchez-Larsen Á, Layos-Romero A, García-García J, et al. . Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. (2020) 95:e1060–70. 10.1212/WNL.0000000000009937
    1. Ellul MA, Benjamin L, Singh B, Michael BD, Easton A, Kneen R, et al. . Neurological associations of COVID-19. Lancet Neurol. (2020) 19:767–83. 10.1016/S1474-4422(20)30221-0
    1. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. (2020) 77:683–90. 10.1001/jamaneurol.2020.1127
    1. Loa Y, Leonga H, Hsua L, Tana T, Kurupa A, Fook-Chonga S, et al. . Autonomic dysfunction in recovered severe acute respiratory syndrome patients. Can J Neurol Sci. (2020) 32:264. 10.1017/S0317167100004108
    1. Goodman BP. Evaluation of postural tachycardia syndrome (POTS). Auton Neurosci. (2018) 215:12–9. 10.1016/j.autneu.2018.04.004
    1. Low PA, Caskey PE, Tuck RR, Fealey RDD, Dyck PJ. Quantitative sudomotor axon reflex testing in normal and neuropathic subjects. Ann Neurol. (1983) 14:573–80. 10.1002/ana.410140513
    1. Low PA, Tomalia VA, Park KJ. Autonomic function tests: some clinical applications. J Clin Neurol. (2013) 9:1–8. 10.3988/jcn.2013.9.1.1
    1. Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. (2020) 3:1–3. 10.1007/s10286-020-00727-9
    1. Logmin K, Karam M, Schichel T, Harmel J, Wojtecki L. Non-epileptic seizures in autonomic dysfunction as the initial symptom of COVID-19. J. Neurol. (2020) 267:2490–1. 10.1007/s00415-020-09904-2
    1. Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. . Guillain-Barre syndrome associated with SARS-CoV-2. N Engl J Med. (2020) 382:2574–6. 10.1056/NEJMc2009191
    1. Su XW, Palka SV, Rao RR, Chen FS, Brackney CR, Cambi F. SARS-CoV-2-associated Guillain-Barré syndrome with dysautonomia. Muscle Nerve. (2020) 62:E48–9. 10.1002/mus.26988
    1. Ghosh R, Roy D, Sengupta S, Benito-León J. Autonomic dysfunction heralding acute motor axonal neuropathy in COVID-19. J Neurovirol. (2020) 26:964–6. 10.1007/s13365-020-00908-2
    1. Thieben MJ, Sandroni P, Sletten DM, Benrud-Larson LM, Fealey RD, Vernino S, et al. . Postural orthostatic tachycardia syndrome: the Mayo Clinic experience. Mayo Clin. Proc. (2007) 82:308–13. 10.1016/S0025-6196(11)61027-6
    1. Sandroni P, Opfer-Gehrking TL, McPhee BR, Low PA. Postural tachycardia syndrome: clinical features and follow-up study. Mayo Clin Proc. (1999) 74:1106–10. 10.4065/74.11.1106
    1. Kasmani R, Elkambergy H, Okoli K. Postural orthostatic tachycardia syndrome associated with mycoplasma pneumoniae. Infect Dis Clin Pract. (2009) 17:342–3. 10.1097/IPC.0b013e318191781b
    1. Pohlgeers KM, Stumbo JR. Syncope in an athlete: a case of infectious mononucleosis induced postural tachycardia syndrome. Curr Sports Med Rep. (2016) 15:41–5. 10.1249/JSR.0000000000000227
    1. Yaxley KL. Infectious mononucleosis complicated by peritonsillar abscess and postural orthostatic tachycardia syndrome: a case report. SAGE Open Med Case Rep. (2020) 8:2050313X20915413. 10.1177/2050313X20915413
    1. Palmero HA, Caeiro TF, Josa DJ. Distinctive abnormal responses to tilting test in chronic Chagas' disease. Klin Wochenschr. (1980) 58:1307–11. 10.1007/BF01478139
    1. Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Postural orthostatic tachycardia syndrome following Lyme disease. Cardiol J. (2011) 18:63–6. 10.1097/MJT.0b013e3181da0763
    1. Noyes AM, Kluger J. A tale of two syndromes: lyme disease preceding postural orthostatic tachycardia syndrome. Ann Noninvasive Electrocardiol. (2015) 20:82–6. 10.1111/anec.12158
    1. Chakraborty T, Kramer CL, Wijdicks EFM, Rabinstein AA. Dysautonomia in guillain-barré syndrome: prevalence, clinical spectrum, and outcomes. Neurocrit Care. (2020) 1:113–20. 10.1007/s12028-019-00781-w
    1. Young RR, Asbury AK, Corbett JL, Adams RD. Pure pan-dysautonomia with recovery. Brain. (1975) 98:613–36. 10.1093/brain/98.4.613
    1. Rubin R. As their numbers grow, COVID-19 “Long Haulers” stump experts. JAMA. (2020) 23:1381–3. 10.1001/jama.2020.17709
    1. Davido B, Seang S, Tubiana R, de Truchis P. Post-COVID-19 chronic symptoms: a postinfectious entity? Clin Microbiol Infect. (2020) 26:1448–9. 10.1016/j.cmi.2020.07.028
    1. Dipaola F, Barberi C, Castelnuovo E, Minonzio M, Fornerone R, Shiffer D, et al. . Time course of autonomic symptoms in postural orthostatic tachycardia syndrome (POTS) patients: Two-year follow-up results. Int J Environmental Res Pub health. (2020) 17:5872. 10.3390/ijerph17165872

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir